Quorum Sensing-IN-3 demonstrates a broad range of bioactivities across various biological processes. It has shown potency in modulating miRNAs and activating promoters such as Rab9, SMN2, and NPC1. It also exhibits inhibitory effects on certain transcriptional activities, including ROR gamma and Menin-MLL interaction, and disrupts DNA repair and genotoxicity. Furthermore, Quorum Sensing-IN-3 has potential antiviral properties, inhibiting viral entry for Lassa Virus, Marburg Virus, and Hepatitis C Virus, as well as interacting with HIV-1 protein Vpr.
In cytotoxicity assays, Quorum Sensing-IN-3 shows an LD50 of greater than 30.0 umol/L against human THP1 cells. It demonstrates antimycobacterial activity with an IC90 of 533,000 nM against Mycobacterium kansasii CIT11/06, and variable antibacterial activity against Staphylococcus epidermidis and methicillin-resistant Staphylococcus aureus, with different IC80 values depending on the duration of exposure.
Quorum Sensing-IN-3 also has been tested for antifungal activity against several strains, including Trichophyton mentagrophytes, Trichosporon asahii, Candida krusei, and Candida albicans, showing differing degrees of effectiveness and IC values across various time points.
Moreover, Quorum Sensing-IN-3 exhibits intrinsic clearance rates in liver cells, with a clearance rate of 64.57 uL/min/(10^6cells)^-1 in rat hepatocytes, 77.62 uL/min/(10^6cells)^-1 in human hepatocytes, and greater than 150.0 mL/min.g^-1 in human liver microsomes. This suggests potential bioactivity related to hepatic clearance processes. Overall, these findings highlight the compound's diverse pharmacological profile..
Note: Summary generated by AI. Data source: ChEMBL 